|
|
||||||||
Eur J Cardiothorac Surg 2007;32:188. doi:10.1016/j.ejcts.2007.03.036
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
Letters to the Editor |
Department of Surgery, Division of Cardiac Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
Received 24 February 2007; accepted 23 March 2007.
* Corresponding author. Address: New Halifax Infirmary, 1796 Summer Street, Room 2269, Halifax, Nova Scotia B3H 3A7, Canada. Tel.: +1 902 473 3808; fax: +1 902 473 4448. (Email: dkalavro{at}dal.ca).
Key Words: Aortic valve replacement Valvuloplasty Stenosis Valve disease
We have read with great interest the two original articles in the January issue of the Journal that report early experiences with transapical aortic valve replacement [1,2]. These studies show that beating-heart transapical aortic valve implantation has acceptable early results in patients deemed to be at too high a risk to allow for a safe valve replacement by conventional surgery. The authors of both studies should be celebrated as innovators and congratulated for their pioneering efforts using these novel technologies.
In these studies, transapical procedures were reserved for patients with preoperative risk profiles that were deemed to be prohibitive for traditional valve replacement such that a successful outcome following conventional surgery was considered unlikely. However, precise inclusion criteria and a definition of inoperability were not provided in these papers. The lack of a transparent patient selection process makes these studies difficult to interpret and compromises the reader's ability to get a sense of the role of these interventions in the management of severe aortic stenosis. Furthermore, we are concerned that much of the preoperative risk stratification in these studies relied on the logistic EuroSCORE. Predictive models including the EuroSCORE have previously been shown to lose discriminatory capability at the extremes of risk [3,4].
To illustrate our point, we have reviewed all consecutive patients undergoing aortic valve replacement at our institution over a 10-year period (19952005). The population evaluated included a total of 1879 consecutive patients. During that time period, there were 325 patients, with a logistic EuroSCORE of greater than 20%, who underwent conventional aortic valve surgery. The average predicted mortality for that group was 39.4% by logistic EuroSCORE. In contrast, we have found in this high-risk group of patients that the observed in-hospital mortality was only 15.1%, which was significantly lower than what was predicted. Therefore, relying on the EuroSCORE to predict preoperative mortality risk may inappropriately classify patients as high-risk patients and unsuitable for conventional aortic valve replacement. Taken further, this may mean that some patients with high EuroSCORE could be denied an intervention that can potentially benefit them.
These studies [1,2] are early feasibility studies and are not randomized controlled trials evaluating two potentially equivalent and equally acceptable interventions. The investigators should interpret their results accordingly and not overstate their conclusions by reporting that this technology is a viable alternative to conventional surgical aortic valve replacement [2]. The issue here is one of good science and not the reluctance to accept an emerging technique.
References
This article has been cited by other articles:
![]() |
T. Walther, V. Falk, M. A. Borger, and F. W. Mohr Reply to Kalavrouziotis et al. Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 189 - 190. [Full Text] [PDF] |
||||
![]() |
J. Ye, S. V. Lichtenstein, and J. G. Webb Reply to Kalavrouziotis et al. Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 188 - 189. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |